Irritable Bowel Syndrome
Irritable Bowel Syndrome (IBS) is a group of disorders which effect the large intestine. The extent to which IBS affects a person's life differs from case to case. The condition affects a person's daily comfort, diet, and exercise. Currently IBS is treated with a variety of medicines dependent on the conditions a person is experiencing.
Further information about IBS can be found by clicking this link.
Below are some of the studies looking at the use of CBD for IBS treatment.
General Information
Can Cannabis Chewing Gum Treat Irritable Bowel Syndrome?
https://www.leafly.com/news/health/can-cannabis-chewing-gum-treat-irritable-bowel-syndrome
​
Can Cannabis Help with Irritable Bowel Syndrome
https://www.royalqueenseeds.com/blog-can-cannabis-help-with-irritable-bowel-syndrome-n402
​
Is Cannabis The Perfect Treatment For Irritable Bowel Syndrome?
http://herb.co/2016/11/15/irritable-bowel-syndrome/
​
Irritable Bowel Syndrome
http://cbdcentral.org/cbd-conditions/irritable-bowel-syndrome-ibs/
​
Cannabidiol in inflammatory bowel diseases: a brief overview
Scientific Research
Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis
https://www.ncbi.nlm.nih.gov/pubmed/22163000
​
Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation
https://www.ncbi.nlm.nih.gov/pubmed/21726418
​
Cannabinoids for gastrointestinal diseases: potential therapeutic applications
http://www.tandfonline.com/doi/abs/10.1517/13543784.12.1.39
​
Selective inhibition of FAAH produces antidiarrheal and antinociceptive effect mediated by endocannabinoids and cannabinoid-like fatty acid amide
http://onlinelibrary.wiley.com/doi/10.1111/nmo.12272/abstract
​
Acute activation of cannabinoid receptors by anandamide reduces gastrointestinal motility and improves postprandial glycemia in mice.
https://www.ncbi.nlm.nih.gov/pubmed/25281429
​
Cannabinoids and the gut: new developments and emerging concepts
https://www.ncbi.nlm.nih.gov/pubmed/20117132
​
Endocannabinoids and the gastrointestinal tract
https://www.ncbi.nlm.nih.gov/pubmed/16751708
​
Cannabinoids and gastrointestinal motility: animal and human studies
https://www.ncbi.nlm.nih.gov/pubmed/18924447
​
Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease
http://www.sciencedirect.com/science/article/pii/S0006295213000543
​